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Mathieu Cayla†, Federico Rojas†, Eleanor Silvester†, Frank Venter† and Keith R. Matthews*†
Abstract 
African trypanosomes cause human African trypanosomiasis and animal African trypanosomiasis. They are transmit-
ted by tsetse flies in sub-Saharan Africa. Although most famous for their mechanisms of immune evasion by antigenic 
variation, there have been recent important studies that illuminate important aspects of the biology of these para-
sites both in their mammalian host and during passage through their tsetse fly vector. This Primer overviews current 
research themes focused on these parasites and discusses how these biological insights and the development of new 
technologies to interrogate gene function are being used in the search for new approaches to control the parasite. 
The new insights into the biology of trypanosomes in their host and vector highlight that we are in a ‘golden age’ of 
discovery for these fascinating parasites.
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What are trypanosomes?
The Trypanosomatidae (Phylum Euglenozoa) are obligate 
parasitic protozoans, which infect all vertebrate classes, 
in addition to insects and plants. Trypanosomatids are 
uniflagellated, and like other organisms in the order Kine-
toplastida, are characterised by a modified mitochondrial 
genome known as the kinetoplast [1, 2]. This is composed 
of DNA ‘mini’- and ‘maxicircles’ [3, 4], which can vary in 
number and catenation depending on the particular spe-
cies [5]. Among the trypanosomatids, Trypanosoma is a 
genus of particular medical and veterinary concern [6, 7]. 
The Salivaria group of trypanosomes, so named for being 
transmitted in the infected saliva of a tsetse fly vector 
(Glossina spp.), is represented by Trypanosoma brucei, 
T. congolense and T. vivax. The former is the most well-
studied of the salivarian trypanosomes, with subspecies 
T. b. gambiense and T. b. rhodesiense being the causa-
tive agents of human African trypanosomiases (HAT). 
The dixenous life-cycle of T. brucei comprises vertebrate 
stages and tsetse stages, which involves differentiation 
through a number of morphological forms, accompanied 
by remodelling of gene expression and metabolic pro-
cesses [8, 9] (Additional file 1). In the bloodstream, two 
morphotypes exist, slender and stumpy forms [10, 11]. 
Slender forms evade the mammalian antibody response 
through antigenic variation, entailing expression of a 
variable surface glycoprotein (VSG) monolayer which 
covers the trypanosome cell. Changes in the expression 
of VSG genes generate antigenically distinct subpopula-
tions, which can evade the host immune response, and 
so sustain the parasite infection [12, 13]. The transition 
from slender to stumpy forms is regulated by a quorum 
sensing (QS) type process which prolongs host survival 
and promotes transmission because stumpy forms are 
non-proliferative in the blood, but preferentially survive 
in and colonise the tsetse midgut.
While T. brucei is certainly a model for trypanosome 
biology, and indeed that of other kinetoplastids, sig-
nificant variation in morphology, transmission, and life-
cycle, exists between different trypanosome species. 
Neither T. vivax nor T. congolense, for example, (both 
causing animal African trypanosomiasis, AAT), show 
morphological differentiation in the bloodstream, though 
both exhibit density-dependent growth control [14, 15]. 
Also, T. b. equiperdum has circumvented the need for an 
arthropod vector altogether, and instead is sexually trans-
mitted between equines. Exciting advances in our under-
standing of trypanosome biology continue to be made, 
in addition to the development of new tools for studying 
these organisms. This Primer will highlight important 
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recent advances in this field, as well as identifying areas 
that warrant investigation in future.
Why study the biology of trypanosomes?
Trypanosomatids diverged from other eukaryotic line-
ages at least 500 million years ago and so provide a valua-
ble model for evolutionarily distinct eukaryotic processes 
[16, 17]. Despite their divergence, they exhibit tractable 
and fascinating biology in terms of their nuclear and 
nucleosome architecture/substructures, transcription, 
organellar segregation, DNA replication, developmen-
tal biology and flagellar motility, for example [18, 19]. 
This tractability has been greatly assisted by the capac-
ity to culture trypanosomatids, to generate different life-
cycle stages and by the development of advanced genetic 
tools. Inducible systems for the regulated ectopic expres-
sion of genes, or RNAi mediated knockdown have been 
widely exploited, with CRISPR-Cas9 genome editing 
[20, 21] recently added to the already large toolbox avail-
able to manipulate trypanosomatid genomes and gene 
expression. As well as their intrinsically interesting biol-
ogy, trypanosomes remain important causes of disease. 
Human cases have reduced in recent years, currently 
at approximately 2000 cases per year, although under-
reporting and the discovery of asymptomatic carriers 
[22] may require revaluation of the prospects for dis-
ease elimination. For the animal disease, trypanosomosis 
remains prevalent and devastating, generating significant 
restrictions on animal productivity in the tsetse belt of 
sub-Saharan Africa.
The genome of T. brucei has 11 megabase-chromo-
somes (~of 35 Mb total) as well as 5 intermediate (200–
300  kb) and ~60–100 mini-chromosomes (30–150  kb) 
[23–25]. The megabase chromosomes are segregated 
via a kinetochore machinery that appears highly diver-
gent with respect to the canonical eukaryotic model 
[26]. Genes are organised and co-transcribed in large 
multi-gene (polycistronic) units [27]. There is little 
evidence of clustering of genes according to life-cycle 
regulation in T. brucei, such that post transcriptional 
mechanisms control gene expression (RNA stability, 
translation, codon usage) [18]. Most protein-coding 
genes are transcribed by RNA polymerase II (RNAP 
II) with the mRNA for all protein-coding genes being 
capped by addition via trans splicing of a 39 nt ‘spliced 
leader’ (SL) sequence, this assisting translation and 
stability. Only two genes have been identified with an 
intron that requires cis splicing [28]. The promoter for 
the SL array, consisting of 100–200 tandem SL RNA 
mini-exons [29], possesses a very divergent RNAP II 
initiation complex [30, 31]. Sites of RNA polymerase 
II initiation in the genome are epigenetically marked, 
being enriched in histone modifications H4K10ac and 
H3K4me3 and four different histone variants that are 
also found at convergent transcription strand switch 
regions [32].
Trypanosoma brucei also possesses a uniquely 
evolved multifunctional RNAP I system, responsible for 
the transcription of ribosomal gene units, as well as the 
major surface proteins procyclins (expressed on tsetse 
midgut forms) and bloodstream VSG genes [33, 34]. 
It is estimated that there are around 10 million copies 
of VSGs on the surface of a parasite shielding invari-
ant surface proteins [35–37]. Trypanosoma brucei pos-
sesses ~2500 VSG genes or pseudogenes [24], located in 
subtelomeric regions of the chromosomes (comprising 
~30% of the genome) [12, 38]. It is now understood that 
during the course of an infection there are up to 100 
VSGs that are expressed in the population at a peak of 
infection with a few variants dominating at each peak, 
allowing immune evasion [13, 39]. In the bloodstream 
stage, there are ~15 telomeric VSG expression sites 
(ES), each containing 8–9 ES associated genes (ESAGs), 
70  bp repeats and a VSG gene [40, 41]. Trypanosoma 
brucei exhibits monoallelic expression of one ES at a 
time allowing the expression of one VSG variant per 
parasite [34, 42, 43]. ES transcription does not occur in 
the nucleolus, unlike other RNAP I transcripts (rRNA, 
procyclin genes [44, 45]), but at an extranucleolar focus 
of RNAP I (the ‘expression site body’) [44, 46, 47]. The 
switch between different ES is controlled epigeneti-
cally [48] and occurs early during the time course of an 
infection [13, 39]. Later, but still early during the infec-
tion, DNA recombination of entire VSG genes occurs 
into the active ES, from mainly telomeric regions, and 
is mediated via the 70 bp repeats. When this repertoire 
is exhausted, recombination occurs from subtelomeric 
array VSGs, with segmental VSGs conversion produc-
ing mosaic VSGs [13, 23, 39, 41, 49–51]. These VSG 
recombinations are dependent on a DNA break [40].
Cytological organisation and flagellar motility have 
also proved fascinating areas of trypanosome biology of 
relevance across eukaryotes. Trypanosomes are highly 
ordered, with their single copy organelles precisely 
positioned and their movements carefully orchestrated 
during cell division [52]. Ultrastructural studies using 
electron microscopy and electron tomography have 
revealed how the microtubule corset of the trypano-
some is co-ordinated with the parasite flagellar basal 
body and flagellum close to the flagellar pocket [53–
56]. This organisation and the experimental tractability 
of trypanosomes has made these organisms invaluable 
as a model for flagellar and ciliary biology in eukaryotic 
organisms [57, 58].
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Three advances in the last decade
High‑throughput phenotyping
With the development of Illumina sequencing, a method 
to survey the representation of genetically distinct cells 
in a complex population was provided. This has proved 
immensely powerful in trypanosome research, allow-
ing a genome-wide RNA interference-based phenotyp-
ing approach (RNAi target sequencing, RIT-seq) [59]. 
Using doxycycline-regulated RNAi induction, cytocidal 
or cytostatic phenotypes that diminish the representation 
of the RNAi-target sequence relative to the population, 
reveals “cold spots” that correspond to predicted mRNA 
sequences. Thus, by combining RNAi and Illumina 
sequencing, it has been possible to identify genes impor-
tant for trypanosome growth in the bloodstream and 
procyclic form as well as during differentiation between 
these forms.
The use of RIT-seq was also applied in positive selec-
tive screens for the identification of genes that contribute 
to drug resistance [60]. Screens were performed using all 
current HAT drugs (Eflornithine, Suramin, Nifurtimox, 
Pentamidine and Melarsoprol) and each yielded a popu-
lation of cells displaying an RNAi-inducible drug resist-
ance phenotype, associated with the downregulation of 
specific genes. These have provided molecular insight 
into the trafficking pathways and resistance mechanisms 
for anti-trypanosomal drugs.
RIT-seq had also been used effectively to explore 
trypanosome biology, an example being its use to dis-
sect the signal-response pathway that promotes stumpy 
formation [61]. Although the quorum sensing signal SIF 
(stumpy induction factor) was unidentified, the screen 
exploited the ability of cell-permeable analogues of 
cAMP or AMP to mimic SIF in laboratory adapted trypa-
nosome lines [62]. By using cAMP analogue-induced cell 
cycle arrest as the selection, genes involved in the signal-
response pathway that promotes stumpy formation were 
identified from the RNAi inserts enriched in outgrowing 
proliferative parasites.
Environmental and cell‑cell communication
Akin to many other single-celled microbes, it has become 
clear that African trypanosomes exhibit social behaviours 
throughout their life-cycle. One example is the coordi-
nated swarming or social motility of T. brucei procyclic 
forms observed on culture plates [63, 64]. cAMP plays a 
role in this phenomenon, with knockdown of the cAMP-
specific phosphodiesterase PDEB1 found to inhibit 
social motility [65], and knockdown of certain adenylate 
cyclases resulting in a ‘hypersocial’ phenotype [66]. This 
is not dissimilar to the role of cyclic-diGMP in bacterial 
swarming motility [67].
Social behavior in bloodstream T. brucei in the form 
of quorum sensing was described in the 1990s [10, 68], 
with the demonstration that differentiation from the 
slender to the stumpy bloodstream form occurred in a 
density-dependent manner resulting from accumulation 
of an unidentified parasite-derived factor. As detailed 
above, the signaling components and RNA regula-
tors that drive the generation of the stumpy form, have 
begun to be revealed in the last decade [61]. Interestingly, 
despite their lack of morphological differentiation in the 
bloodstream, the signaling components required to per-
ceive and respond to the density-signal in T. brucei are 
conserved in T. congolense. Moreover, T. congolense pro-
duces a QS signal that causes T. brucei to differentiate 
to stumpy forms in mixed infections [69], revealing that 
inter-species QS is possible, just as occurs in bacterial 
communities.
Consistent with the trypanosome’s reliance on post-
transcriptional gene regulation, a number of RNA-bind-
ing proteins have been found to play important roles in 
trypanosome biology [70]. For instance, overexpres-
sion of a single RNA-binding protein, RBP6, causes the 
spontaneous progression from procyclic forms to epi-
mastigote and metacyclic forms in culture, mimicking 
the transitions occurring in the tsetse fly vector [71]. 
Another RNA-binding protein was found to be involved 
in maintenance of the bloodstream form developmen-
tal state, with RBP10 binding certain procyclic-specific 
transcripts and targeting them for repression [72]. Inter-
estingly, regulatory RNA-binding proteins seem to domi-
nate during the control of developmental gene expression 
as the parasite transitions between life-cycle stages; levels 
of constitutively expressed transcripts are, in contrast, 
apparently governed by codon usage bias [73, 74].
A more nuanced picture of infection
Several developments have reshaped our view of the 
trypanosome infection dynamic and its interactions in a 
host context.
First, the perception of trypanosome infections as 
comprising cyclical ‘waves’ of parasitaemia in the blood-
stream is now recognised as overly simplistic. Thus, 
rather than a procession of antigenic variants arising 
sequentially over time, it is now clear that there is con-
siderable complexity in VSG expression dynamics, with 
many simultaneously expressed VSGs present within 
chronic infections albeit comprised of major and minor 
types [13, 39]. Chronic infections also do not involve 
an alternating fluctuation between mainly slender and 
mainly stumpy forms dependent on the overall parasi-
taemia, with instead, transmissible stumpy forms found 
to be prevalent throughout long-term infections in mice 
[75]. It was suggested that by limiting the number of 
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slender forms, which can generate new antigenic vari-
ants, the parasites preserve their repertoire of available 
VSG types whilst also prolonging host survival and so 
maximizing the probability of transmission.
Secondly, we now understand how human infectivity is 
possible for some African trypanosomes. Subspecies of T. 
brucei, T. b. gambiense and T. b. rhodesiense, are the only 
African trypanosomes able to successfully establish in a 
human host, because other species are killed by the tryp-
anolytic serum component, apolipoprotein L1 (APOL1). 
Trypanosoma b. rhodesiense has bypassed this defense 
through the evolution of Serum resistance associated 
(SRA) protein, derived from truncation of a VSG [76, 77]. 
The mechanisms by which T. b. gambiense outmaneuvers 
human defenses have taken longer to resolve but involve 
a role for T. b. gambiense-specific glycoprotein (TgsGP), 
deletion of which restored parasite sensitivity to human 
serum [78, 79]. Development of a recombinant Papio 
papio APOL1 mutant that could inhibit T. b. gambiense 
infection of mice illustrates how an increased knowledge 
of host-parasite interactions can open up new therapeu-
tic possibilities [80].
Thirdly, the perception of trypanosomiasis as largely 
being a bloodstream infection has been revised. Trypa-
nosoma brucei, for instance, can be found in abundance 
within adipose tissue. Adipose tissue parasites are tran-
scriptionally distinct from those in the bloodstream, 
and may utilize fatty acids as a carbon source, indicating 
adaptation to their environment [81]. Pockets of T. brucei 
have also been found in the skin [22, 82]. The blood-brain 
barrier makes it challenging to effectively target parasites 
residing in the brain during drug treatment of late stage 
trypanosomiasis and parasites in the adipose tissue and 
skin may present a similar challenge for drug delivery. 
Drug efficacy may also be influenced by pharmacoki-
netic parameters which differ during the circadian cycle. 
Although hosts exhibit well defined circadian rhythms, 
trypanosome gene expression has also been shown to 
demonstrate circadian oscillation [83]. These oscillations 
can be observed in culture, following a period of entrain-
ment, generating periodic peaks and troughs in the 
transcript levels of genes linked to metabolic processes. 
Interestingly, T. brucei infection can also disrupt the nor-
mal circadian rhythm of a murine host, leading to the 
proposition that sleeping sickness in humans represents 
a parasite-induced circadian disease [84].
Three areas ripe for development
Coherent assembly of signalling pathways and complexes
The ability of trypanosomes to sense and respond to 
changes in their environment is essential for their sur-
vival. However, the mechanisms underlying the trans-
duction of extracellular signals is poorly understood, 
with most studies focusing on the function of indi-
vidual molecules or molecular classes (e.g. kinases). 
Nonetheless, the development of high throughput tech-
nologies has allowed the analysis of signalling pathways 
at a genome-wide scale in trypanosomes. For example, 
in the QS response generating stumpy forms, compo-
nents that fell into a potential hierarchical organisation 
were identified [61, 85]. To assemble these into a coher-
ent pathway, a concerted knock-out and overexpres-
sion approach has been used, revealing dependencies 
between individual components [86]. With systematic 
gene ablation and mutation now possible via CRISPR/
Cas9 [20], this approach can be extended to understand 
how components connect to transduce external cues. 
Refinements in transcriptome analysis, proteomics and 
phosphoproteomics can further enhance the resolution 
of signal network analysis and extend the understand-
ing of the associated molecular interactions. Any exter-
nal cue that generates a defined phenotypic response 
is accessible to dissection by an integration of these 
selection and analytical approaches, promising a more 
coherent understanding of how parasites interact with 
and respond to their environment to alter life history 
traits.
The comparative biology of African trypanosome species
Although T. brucei has been the long-established model 
for African trypanosome biology, the reduced impor-
tance of human infections and the recognition of the 
distinct biology of T. congolense and T. vivax has gen-
erated renewed interest in these parasites. Research 
articles focused on T. congolense and T. vivax infections 
in the field have provided important insight into the 
dynamics of infection, host resistance and pathology, 
as well as prevalence of individual species in livestock, 
wild animals and tsetse flies. In contrast, knowledge of 
the molecular biology of T. congolense and T. vivax has 
lagged behind the wealth of information accumulated 
for T. brucei. The recent advances in culture techniques 
and genetic manipulation of T. congolense [87, 88] and 
T. vivax [89] will enable similar strides to be made in 
the understanding of the distinct cell biology of these 
important veterinary pathogens. Each African trypano-
some species has developed significant and surprisingly 
distinct adaptations to their hosts, for example in their 
predicted surface-expressed proteins [90] and VSG 
gene archive and expression architecture [91, 92]. Each 
also shows a distinct developmental path in their tsetse 
fly vector [9]. It is now clear that we will not be able 
to fully rely on extrapolating information from T. bru-
cei when it comes to investigating the biology of other 
trypanosome species.
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Host‑parasite‑vector interactions
Like other parasites, the fate of African trypanosomes is 
tied to interactions with their host, at least until they can 
escape to another host via their tsetse fly vector. Whilst 
immune evasion is one mechanism, trypanosomes also 
interact with the host immune system with the poten-
tial to regulate the course of infection, either through 
antibody clearance [93] or immune suppression [94]. 
These host-parasite interactions create the potential for 
genotype-by-genotype (G×G) interactions which can 
influence the virulence (parasite numbers) and pathology 
(disease) generated by parasites in the field. Virulence is 
often counterbalanced by the transmission benefits of 
infection chronicity, with the potential to generate evo-
lutionary interactions between trypanosomes and their 
hosts. This is particularly complex for African trypano-
somes which, unlike many parasites, have the ability to 
infect many mammalian host species, and can also exist 
in mixed coinfections with other trypanosome species. 
The tools and information to explore these interactions 
are emerging as different trypanosome species become 
genetically tractable and there is an expanding dataset of 
genomic sequences for field isolates. There is also a new 
focus on the interaction between the parasite and innate 
and acquired immune mechanisms [94, 95].
The passage of the trypanosome through the tsetse fly 
is also increasingly accessible, using sophisticated live 
cell microscopy [96], the development of labelled trypa-
nosome lines which can be tracked during their journey 
in the insect vector [97] and the establishment of tools 
for the manipulation of tsetse gene expression using 
RNAi [98]. Exploring the tsetse-parasite interaction has 
also become tractable through increased sensitivity in 
transcriptome analyses using RNA-seq [99–101] and 
biochemical and proteomic analysis of the parasite meta-
bolic pathways in the fly midgut [102–104]. All of these 
developments can also be deployed to understand the 
comparative transmission biology of different trypano-
some species, given the distinct developmental paths of 
T. brucei, T. congolense and T. vivax through their vector 
[105]. Analyses of the interface between the trypanosome 
in the host and in their vector represent important stud-
ies because targeting parasite transmission remains the 
most effective and cost-efficient route to disease control 
[106].
Finally, the interaction between the trypanosome 
and its host in different compartments must be under-
stood. The recent exciting discoveries of the novel niches 
exploited by trypanosomes in their mammalian host 
raises questions about the parasite’s biochemistry, drug 
sensitivity and immune susceptibility in these compart-
ments, and their kinetics of exchange with the blood-
stream population [107, 108]. These adaptations may 
also differ between different trypanosome species with 
consequences for drug efficacy in cattle populations with 
mixed infections, in particular.
Conclusions
Trypanosomes continue to provide important insights to 
the evolution of eukaryotic cells, while remaining signifi-
cant pathogens in sub-Saharan Africa. In combination, 
this makes the continued analysis of trypanosome biol-
ogy compelling. With respect to fundamental biology, 
the unusual kinetochore composition in trypanosomatids 
has gained significant interest in the wider cell biology 
community, as has their unique mitochondrial biology 
and flagellar dynamics. Significant progress has also been 
made in therapeutics for these parasites, with several 
compounds at different stages of the drug development 
pipeline, most notably fexinidazole [109] and oxaboroles 
[110]. This has resulted from significant investment in the 
discovery of small molecule therapeutics which offer oral 
delivery and reduced toxicity. Similarly, the innovations 
in gene technology, including high throughput genetic 
screens, comprehensive protein localisation approaches 
([111] http://trypt ag.org) and the application of CRISPR 
technology to laboratory adapted and developmentally 
competent trypanosome lines have accelerated under-
standing of the parasite’s biology whilst helping the pre-
diction of how drug resistance might emerge to new 
therapies. The first golden age of trypanosome biol-
ogy was in the 1900s when the disease agent and vec-
tor was identified, and the second was in the 1980s and 
early 1990s where the unusual molecular mechanisms of 
trypanosomes were uncovered, particularly in relation to 
antigenic variation. We are currently in the third golden 
age, where this molecular understanding is applied to the 
fascinating biology of the parasite in the host and in the 
field, and for the discovery of new therapies.
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